Comparing Sanuwave Health (NASDAQ:SNWV) & INLIF (NASDAQ:INLF)

Sanuwave Health (NASDAQ:SNWV) and INLIF (NASDAQ:INLF) are both small-cap medical companies, but which is the superior business? We will compare the two companies based on the strength of their dividends, valuation, institutional ownership, analyst recommendations, earnings, risk and profitability.

Analyst Recommendations

This is a breakdown of current ratings and recommmendations for Sanuwave Health and INLIF, as provided by MarketBeat.com.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Sanuwave Health	1	1	1	1	2.50
INLIF	1	0	0	0	1.00

Sanuwave Health presently has a consensus price target of $51.00, suggesting a potential upside of 201.78%. Given Sanuwave Health’s stronger consensus rating and higher possible upside, analysts clearly believe Sanuwave Health is more favorable than INLIF.

Insider & Institutional Ownership

42.5% of Sanuwave Health shares are held by institutional investors. 14.9% of Sanuwave Health shares are held by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock is poised for long-term growth.

Volatility & Risk

Sanuwave Health has a beta of 1.51, suggesting that its stock price is 51% more volatile than the S&P 500. Comparatively, INLIF has a beta of 3.39, suggesting that its stock price is 239% more volatile than the S&P 500.

Valuation and Earnings

This table compares Sanuwave Health and INLIF”s revenue, earnings per share (EPS) and valuation.

	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Sanuwave Health	$44.05 million	3.30	$11.81 million	($0.16)	-105.63
INLIF	$18.41 million	0.33	-$5.45 million	N/A	N/A

Sanuwave Health has higher revenue and earnings than INLIF.

Profitability

This table compares Sanuwave Health and INLIF’s net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
Sanuwave Health	26.64%	-141.56%	34.53%
INLIF	N/A	N/A	N/A

Summary

Sanuwave Health beats INLIF on 11 of the 13 factors compared between the two stocks.

About Sanuwave Health

SANUWAVE Health, Inc., a shock wave technology company, researches, develops, and commercializes noninvasive, high-energy, and acoustic shock waves for regenerative medicine and other applications in the United States and internationally. Its shockwaves are used to produce a biological response resulting in the body healing itself through the repair and regeneration of tissue, and musculoskeletal and vascular structures. The company’s lead regenerative product is the dermaPACE device for treating diabetic foot ulcers. Its portfolio of healthcare products and product candidates activate biologic signaling and angiogenic responses, including new vascularization and microcirculatory improvement, which helps to restore the body’s normal healing processes and regeneration. The company also focuses on applying its Pulsed Acoustic Cellular Expression technology in wound healing, orthopedic, plastic/cosmetic, and cardiac conditions. In addition, it offers UltraMIST, non-contact and non-thermal ultrasound therapy device used to treat diabetic foot ulcers, pressure ulcers, venous leg ulcers, deep tissue pressure injuries, and surgical wounds; and orthoPACE system to treat tendinopathies and acute and nonunion fractures. The company was founded in 2005 and is headquartered in Suwanee, Georgia.

About INLIF

INLIF Ltd. is a holding company, which engages in the development of injection molding machine-dedicated manipulator arms. Its products include: Three-axis robot, Five-axis robot and bull head type manipulator. The company was founded on January 4, 2023 and is headquartered in Quanzhou, China.